Galapagos NV
AEX:LKFT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Galapagos NV
AEX:LKFT
|
BE |
|
U
|
UBS Group AG
SWB:0UB
|
CH |
|
Anima Holding SpA
MIL:ANIM
|
IT |
|
V
|
Verisk Analytics Inc
XMUN:VA7A
|
US |
|
Fisher & Paykel Healthcare Corporation Ltd
F:FPLB
|
NZ |
|
Pepkor Holdings Ltd
F:S1VA
|
ZA |
|
D
|
Delivery Hero SE
DUS:DHER
|
DE |
|
OMV AG
SIX:OMV
|
AT |
|
Samsung C&T Corp
KRX:028260
|
KR |
|
A
|
Archer-Daniels-Midland Co
BMV:ADM
|
US |
|
S
|
Sunrun Inc
DUS:3S9
|
US |
|
Antofagasta PLC
LSE:ANTO
|
UK |
|
O
|
OMV AG
SWB:OMV
|
AT |
|
Basf Se
XETRA:BAS
|
DE |
|
Euronet Worldwide Inc
NASDAQ:EEFT
|
US |
|
A
|
Ageas SA
OTC:AGESY
|
BE |
|
F
|
Frontier Lithium Inc
OTC:LITOF
|
CA |
|
B
|
Basf Se
SWB:BAS
|
DE |
|
K
|
Koninklijke Philips NV
XHAM:PHI1
|
NL |
|
J
|
Just Eat Takeaway.com NV
XMUN:T5W
|
NL |
|
B
|
BP PLC
XMUN:BPE5
|
UK |
|
O
|
Olympia Financial Group Inc
TSX:OLY
|
CA |
|
S
|
SLM Corp
F:SM1
|
US |
|
I
|
Identiv Inc
SWB:INVN
|
US |
Bankruptcy Probability
Galapagos NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Galapagos NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BE |
|
Galapagos NV
AEX:GLPG
|
1.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
461.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
69.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Galapagos NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Galapagos NV has total debt of 5.2m EUR. This includes both short-term (0 EUR) and long-term (5.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.
